A North Carolina patient’s doctor’s office called five days after an AI tool drafted his insurance appeal, with good news: his medication was approved.
Quick Take
- A documented case links an AI-written appeal letter to a drug approval just five days later.
- Tools like Claimable and Counterforce Health write custom appeal letters using medical records, policy terms, and past winning cases.
- Fewer than 1 percent of denied health claims get appealed, even though many appeals succeed.
- Costs run from free to about $40 per letter, far cheaper than hiring a lawyer or patient advocate.
A Drug Denial Turns Into Approval Within Days
Time magazine reported on November 12, 2026 that a patient used the AI tool Claimable to fight a denial for Remicade, a drug used to treat serious inflammatory conditions. The tool built an appeal around his missed workdays and pointed to federal laws that require coverage of medically necessary treatment. Five days after he submitted it, his doctor’s office confirmed the insurer had approved the drug.
That case isn’t a one-off experiment. NBC News reported in July 2025 that companies like Claimable and Counterforce Health already run working products. These tools take a patient’s diagnosis, policy details, and medical history, then write a letter packed with clinical research and records of other patients who won similar appeals. The process that once took weeks of phone calls and paperwork now takes minutes to start.
Why So Few People Fight Back
Most people never appeal a denied claim, even when the odds favor them. Research from KFF found that in 2024, insurers denied about one in five in-network claims under Affordable Care Act marketplace plans, yet consumers appealed less than 1 percent of those denials. Back in 2017, the overturn rate for appeals that did get filed averaged 14 percent, with some insurers reversing more than 80 percent of challenged denials. The gap between how often people could win and how often they even try is the real problem AI tools are built to close.
PBS NewsHour reported in November 2025 that these apps ask patients simple questions about their diagnosis, treatment, and denial letter. The software then fills in the kind of documentation insurers expect to see, producing a finished appeal for roughly $40 to $50. Counterforce Health, one of the companies building these tools, describes its mission as giving ordinary patients the same firepower that insurance companies already use against them.
What The Tools Actually Do
These apps don’t guess. Investopedia reported that Claimable pulls in peer-reviewed medical studies along with state and federal laws, then matches that evidence to the patient’s specific denial reason. The software organizes scattered medical records into one clear argument, something that used to require a lawyer or a patient advocate who charged hundreds of dollars an hour. For families already drowning in medical bills, that cost difference matters enormously.
Supporters argue this is exactly the kind of market solution conservatives should welcome: private companies using technology to help regular people stand up to large institutions, without needing a new government program or regulation. A patient with a denied claim doesn’t need a committee hearing. He needs a tool that works on his kitchen table at midnight, and that’s what these apps deliver.
The Bigger Fight Ahead
Insurers aren’t standing still either. PBS reporting noted concerns that insurance companies could use their own AI systems to spot which patients are unlikely to appeal, then target those claims for denial first. That raises a real question about whether this becomes an arms race between insurer algorithms and patient algorithms, with regular families caught in the middle. It also explains why lawsuits have emerged questioning whether insurer AI systems override doctors’ judgment without enough human review.
One brief caveat is worth noting: individual success stories, however well documented, don’t tell us the average odds for every patient who tries these tools. Still, the facts on the ground are clear. Patients today have a faster, cheaper way to push back against a denial than they did even two years ago, and the data shows plenty of denials are winnable once someone actually files the paperwork.
Sources:
time.com, wheninyourstate.com, nbcnews.com, pbs.org, kff.org
